The UK’s pharmaceutical sector is ‘an export success story’, enjoying a competitive advantage and generating a sizeable trade surplus. This …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

